72 related articles for article (PubMed ID: 8644532)
1. [Evaluation of risk factors of interferon-associated retinopathy in patients with type C chronic active hepatitis].
Soushi S; Kobayashi F; Obazawa H; Kigasawa K; Shiraishi K; Itakura M; Matsuzaki S
Nippon Ganka Gakkai Zasshi; 1996 Jan; 100(1):69-76. PubMed ID: 8644532
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factors of retinopathy in Egyptian patients with chronic hepatitis C virus treated with pegylated interferon plus ribavirin.
Fouad YM; Khalaf H; Ibraheem H; Rady H; Helmy AK
Int J Infect Dis; 2012 Jan; 16(1):e67-71. PubMed ID: 22115957
[TBL] [Abstract][Full Text] [Related]
3. Retinal complications with elevated circulating plasma C5a associated with interferon-alpha therapy for chronic active hepatitis C.
Sugano S; Yanagimoto M; Suzuki T; Sato M; Onmura H; Aizawa H; Makino H
Am J Gastroenterol; 1994 Nov; 89(11):2054-6. PubMed ID: 7942735
[TBL] [Abstract][Full Text] [Related]
4. [Interferon-associated retinopathy].
Okuno H; Hirota T; Shiozaki Y; Inoue K; Hagihara M; Sugasawa K; Okami T
Nihon Rinsho; 1994 Jul; 52(7):1919-23. PubMed ID: 7521439
[TBL] [Abstract][Full Text] [Related]
5. Retinal complications during interferon therapy for chronic hepatitis C.
Kawano T; Shigehira M; Uto H; Nakama T; Kato J; Hayashi K; Maruyama T; Kuribayashi T; Chuman T; Futami T; Tsubouchi H
Am J Gastroenterol; 1996 Feb; 91(2):309-13. PubMed ID: 8607498
[TBL] [Abstract][Full Text] [Related]
6. Interferon may cause retinopathy during hepatitis therapy.
Shahidullah AB; Cerulli MA; Berman DH
Am J Gastroenterol; 1995 Sep; 90(9):1543. PubMed ID: 7661198
[No Abstract] [Full Text] [Related]
7. Is screening for interferon retinopathy in hepatitis C justified?
Cuthbertson FM; Davies M; McKibbin M
Br J Ophthalmol; 2004 Dec; 88(12):1518-20. PubMed ID: 15548803
[TBL] [Abstract][Full Text] [Related]
8. [Depression during interferon therapy in chronic hepatitis C patients--a prospective study].
Otsubo T; Miyaoka H; Kamijima K; Onuki M; Ishii M; Mitamura K
Seishin Shinkeigaku Zasshi; 1997; 99(3):101-27. PubMed ID: 9136611
[TBL] [Abstract][Full Text] [Related]
9. Interferon-associated retinopathy in a uniform regimen of natural interferon-alpha therapy for chronic hepatitis C.
Saito H; Ebinuma H; Nagata H; Inagaki Y; Saito Y; Wakabayashi K; Takagi T; Nakamura M; Katsura H; Oguchi Y; Ishii H
Liver; 2001 Jun; 21(3):192-7. PubMed ID: 11422782
[TBL] [Abstract][Full Text] [Related]
10. Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis.
d'Alteroche L; Majzoub S; Lecuyer AI; Delplace MP; Bacq Y
J Hepatol; 2006 Jan; 44(1):56-61. PubMed ID: 16223542
[TBL] [Abstract][Full Text] [Related]
11. [Thyroid dysfunction in patients with chronic hepatitis C pre and post treatment with interferon].
Martín-Vivaldi R; Nogueras F; Quintero D; Espinosa MD; López de Hierro M; Suárez JF; González A
Rev Esp Enferm Dig; 1996 Jul; 88(7):480-4. PubMed ID: 8924326
[TBL] [Abstract][Full Text] [Related]
12. Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis receiving interferon alfa.
Hayasaka S; Fujii M; Yamamoto Y; Noda S; Kurome H; Sasaki M
Br J Ophthalmol; 1995 Feb; 79(2):150-2. PubMed ID: 7696235
[TBL] [Abstract][Full Text] [Related]
13. [Interferon-induced retinal changes].
Chuman T; Nao-i N; Sawada A; Kawano T; Shigehira M
Nippon Ganka Gakkai Zasshi; 1994 Jun; 98(6):616-21. PubMed ID: 7518188
[TBL] [Abstract][Full Text] [Related]
14. Ocular complications with high-dose interferon alpha in chronic active hepatitis.
Kadayifcilar S; Boyacioglu S; Kart H; Gursoy M; Aydin P
Eye (Lond); 1999 Apr; 13 ( Pt 2)():241-6. PubMed ID: 10450390
[TBL] [Abstract][Full Text] [Related]
15. [Severe thrombocytopenia during interferon-alpha therapy for chronic active hepatitis C associated with systemic lupus erythematosus].
Kimura Y; Kajiyama K; Nomura H; Shiraishi G
Fukuoka Igaku Zasshi; 1994 Nov; 85(11):329-33. PubMed ID: 7851835
[TBL] [Abstract][Full Text] [Related]
16. The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C.
Watanabe U; Hashimoto E; Hisamitsu T; Obata H; Hayashi N
Am J Gastroenterol; 1994 Mar; 89(3):399-403. PubMed ID: 8122653
[TBL] [Abstract][Full Text] [Related]
17. [Cryoglobulinemia in chronic hepatitis C. Improvement by alpha-interferon is independent of virus elimination].
Glück T; Dürk H; Kötter I; Zimmermann C; Saal JG
Med Klin (Munich); 1995 Dec; 90(12):674-80. PubMed ID: 8583982
[TBL] [Abstract][Full Text] [Related]
18. Response of chronic hepatitis C to interferon-alpha treatment and relationship with iron metabolism.
Martín-Vivaldi R; Nogueras F; González A; Quintero D; Pinel LM; Castro T; Hernández A
Rev Esp Enferm Dig; 1997 Jul; 89(7):523-30. PubMed ID: 9265838
[TBL] [Abstract][Full Text] [Related]
19. [A case of allograft rejection induced by the interferon-alpha therapy to hepatitis type C after renal transplantation].
Kakimoto K; Takahara S; Kokado Y; Kameoka H; Ishibashi M; Okuyama A; Kyo M; Nagano S
Hinyokika Kiyo; 1994 Jun; 40(6):529-32. PubMed ID: 8073963
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
